Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Revista Da Associacao Medica Brasileira (1992)|April 1, 2026
Clinical impact of TP53 mutation status on survival outcomes in metastatic colorectal cancerOğuzhan Yıldız, Hakan Şat Bozcuk, Melek Karakurt Eryılmaz, et al.
Journal of Gastrointestinal Cancer|April 11, 2022
Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal CancerTuba Karaçelik, Buğra Kaya, Mustafa Korkmaz, et al.
Journal of Cancer Research and Therapeutics|October 16, 2024
Extensive metastatic ependymoma with long-term progression-free survival with capecitabine plus temozolomide combination chemotherapy: A case reportEngin Hendem, Mustafa Korkmaz, Murat Araz, et al.
European Journal of Clinical Pharmacology|March 13, 2024
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first lineMustafa Korkmaz, Melek Karakurt Eryılmaz, Mehmet Zahid Koçak, et al.
Medicina (Kaunas, Lithuania)|June 26, 2026
Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center StudyEngin Hendem, Mehmet Zahid Koçak, Oguzhan Yıldız, et al.
Journal of Cancer Research and Clinical Oncology|July 2, 2025
Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experienceOğuzhan Yıldız, Melek Karakurt Eryılmaz, Ali Fuat Gürbüz, et al.
International Archives of Allergy and Immunology|January 17, 2026
Real-World Outcomes of Rapid Drug Desensitization for Taxane and Platinum ChemotherapyFerhat Sağun, Fatih Çölkesen, Mehmet Emin Gerek, et al.
European Journal of Clinical Pharmacology|December 15, 2022
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancerDilek Çağlayan, Mehmet Zahid Koçak, Çağlayan Geredeli, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2023
The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) studyAykut Demirkıran, Fahriye Kılınç, Mehmet Zahid Koçak, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 28, 2024
Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapyMurat Araz, Ismail Beypinar, Fatih Inci, et al.
Pageof 9